November 30, 2021 by Chain Drug Review
GEHE Pharma Handel (GEHE) and Alliance Healthcare Deutschland (AHD), McKesson Corp., WBA
Business, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and McKesson Corp. have reached an agreement on Tuesday for WBA to acquire the remaining 30% share of their GEHE Pharma Handel (GEHE) and Alliance Healthcare Deutschland (AHD) joint venture. Following this transaction, WBA will become the 100% owner of the combined GEHE and Alliance Healthcare businesses in
November 8, 2021 by Jeffrey Woldt
Roz Brewer, WBA
November 8, 2021, Opinion
In laying out her vision for the future of Walgreens Boots Alliance at the company’s investor day last month, chief executive officer Roz Brewer framed the strategy in personal terms. Recalling her mother’s final illness a decade ago, Brewer talked about the daunting complexity and wastefulness of health care in America, and how WBA is
October 21, 2021 by Chain Drug Review
Boots, WBA
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) announced Thursday that it is expanding Mental Health First Aid training for more than 27,000 Walgreens pharmacists, while Boots is introducing new services aimed at helping to meet the growing need in communities across Europe and the UK. According to the Centers for Disease Control and Prevention (CDC),
October 14, 2021 by Chain Drug Review
Roz Brewer, VillageMD and CareCentrix, Walgreens Health, WBA
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) launched on Thursday its new consumer-centric health care strategy to drive sustainable, long-term profitable growth. The plan features the launch of Walgreens Health, a new business segment enabled by investments in VillageMD and CareCentrix, accelerating the company’s capabilities in primary care, post-acute care and home care. The strategic
October 14, 2021 by Chain Drug Review
Roz Brewer, Village MD, WBA
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) has agreed to make an additional investment in VillageMD to advance its strategic position in the delivery of value-based primary care, a $1 trillion, fast-growing segment of the health care system. The companies said on Thursday that the $5.2 billion investment will accelerate the opening of at least
October 14, 2021 by Chain Drug Review
fourth quarter, Roz Brewer, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance beat Wall Street’s expectations for fourth quarter revenue and earnings, with COVID-19 vaccinations and tests boosting traffic and demand rising for cough-cold medications and vitamins. Walgreens administered 13.5 million vaccines during the three months ended August 31 — almost double the 7 million it had expected to provide. Adjusted
October 8, 2021 by Chain Drug Review
Vitamin Angels, WBA
Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA), in collaboration with Vitamin Angels, announced on Friday that more than 300 million women and children around the world have received life-changing vitamins and minerals through their eight-year partnership. The two also announced a new goal: Reaching 500 million women and children by the end of August 2025,
September 21, 2021 by Chain Drug Review
Shields Health Solutions, WBA
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and Shields Health Solutions announced on Tuesday that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in Shields, an industry leader in integrated, health system-owned specialty pharmacy care. WBA’s investment signifies another step the company is taking to accelerate innovative healthcare models for future
August 27, 2021 by Chain Drug Review
Roz Brewer, Walgreens, WBA
Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. has named Tracey Brown to the newly created post of president of retail products and chief customer officer at Walgreens. The appointment, one of three announced Friday at WBA, is meant to emphasize Walgreens’ customer experience across all consumer touchpoints, the company said. WBA also named Danielle Gray
July 1, 2021 by Chain Drug Review
Brewer, third quarter, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill.— Walgreens Boots Alliance easily beat Wall Street’s estimates for third quarter sales and earnings, and raised its full year guidance. WBA’s adjusted earnings per share of $1.51 far surpassed analysts’ expectation of $1.17. Sales for the period ended May 31 rose 12.1% to $34.03 billion, topping the projected $33.76 billion. The gain reflecting
May 17, 2021 by Jeffrey Woldt
CVS Health, VillageMD, WBA
May 17, 2021, Opinion
People involved in the industry commonly refer to the companies at its center as chain pharmacies. The trajectory of the business over the past 15 or 20 years has, however, arguably made the term something of a misnomer. During that period, CVS Health, among others, entered pharmacy benefits management; Walgreens Boots Alliance carved out a
May 17, 2021 by David Pinto
Alex Gourlay, WBA
May 17, 2021, Opinion
Reports from sources close to Walgreens Boots Alliance to the effect that the company’s talented and personable senior executive Alex Gourlay was, for now at least, preparing for retirement brought a sharper reaction from the chain drug community than so important a transition usually elicits. The response was primarily the natural result of the affection
May 7, 2021 by Chain Drug Review
COVID-19 in India, Roz Brewer, WBA
Leading Headlines, Pharmacy
DEERFIELD, Ill. — To help address the critical need for COVID-19-related resources during a surge in cases and deaths in India, Walgreens Boots Alliance (WBA) announced Friday a commitment of US$350,000 to the American India Foundation (AIF). For a total of $350,000 or more, WBA will: provide a direct donation of $100,000 allow its team
March 31, 2021 by Chain Drug Review
Brewer, second quarter, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. _ Walgreens Boots Alliance’s second quarter earnings easily beat analysts’ projections, as sales rose 4.6% to $32.8 billion. WBA posted adjusted earnings of $1.21 billion, or $1.40 per share, well ahead of Wall Street’s estimate of $1.11. The company elevated its full year guidance to mid-to-high single digit growth in constant currency adjusted